Warning: The NCBI web site requires JavaScript to function. more...
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA.
Breast Cancer Res. 2008;10(2):R38. Epub 2008 Apr 30.
Related citations
Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study.
Danforth KN, Gierach GL, Brinton LA, Hollenbeck AR, Katki HA, Leitzmann MF, Schatzkin A, Lacey JV Jr.
Cancer Prev Res (Phila). 2009 May;2(5):466-72. Epub 2009 Apr 28.
Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE.
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):261-4.
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI.
JAMA. 2004 May 26;291(20):2433-40.
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR.
Breast Cancer Res Treat. 2011 Feb;126(1):149-55. Epub 2010 Jul 29.
Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.
J Natl Cancer Inst. 2007 Jun 6;99(11):881-9.
Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW, Anderson KE, Lazovich D, Folsom AR.
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1586-91.
Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD.
Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ.
Int J Cancer. 2007 Jul 1;121(1):211-15.
Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.
Eur J Cancer Prev. 2008 Apr;17(2):88-96.
Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.
Lew JQ, Freedman ND, Leitzmann MF, Brinton LA, Hoover RN, Hollenbeck AR, Schatzkin A, Park Y.
Am J Epidemiol. 2009 Aug 1;170(3):308-17. Epub 2009 Jun 18.
Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings.
Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B.
Am J Epidemiol. 2007 Sep 15;166(6):709-16. Epub 2007 Jul 27.
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.
Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.
BMC Cancer. 2005 Dec 12;5:159.
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A; Women's Health Initiative.
Cancer Res. 2003 Sep 15;63(18):6096-101.
Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.
J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.
Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.
Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38. Epub 2011 Mar 15.
A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.
J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P.
J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405.
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.
Daugherty SE, Pfeiffer RM, Sigurdson AJ, Hayes RB, Leitzmann M, Schatzkin A, Hollenbeck AR, Silverman DT.
Am J Epidemiol. 2011 Apr 1;173(7):721-30. Epub 2011 Mar 2. Review.
Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.
Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM.
Breast Cancer Res. 2006;8(6):R71.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on